Bicara Therapeutics

Bicara Therapeutics

A clinical-stage company developing first-in-class biologics engineered to bring together the precision of targeted therapy and the power of tumor modulators. .

HQ location
Cambridge, United States
Website
Launch date
Employees
Market cap
$650m
Enterprise value
$215m
Share price
$11.91 BCAX
Authorizing premium user...